Release Date: 22/04/16 09:42 Summary: Annual Report to shareholders-E88.AX Price Sensitive: No Download Document 1012.76KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%